A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/385 (2006.01) A61K 38/19 (2006.01) C07K 14/52 (2006.01)
Patent
CA 2670460
The invention relates to compositions for the treatment of TH2 mediated inflammatory conditions. The compositions are vaccines comprising a non-primate TSLP or fragments thereof to be used as a vaccine to treat humans with excessive TH2 mediated inflammatory conditions. For the treatment of TH2 mediate inflammatory conditions in other non-human mammals the TSLP of the species to be vaccinated is being used as antigen.
L'invention concerne des compositions destinées au traitement de troubles inflammatoires induits par TH2. Ces compositions consistent en des vaccins contenant un TSLP non primate ou des fragments de celui-ci destiné à être utilisé en tant que vaccin afin de traiter des êtres humains présentant des troubles inflammatoires induits par un excès de TH2. Pour le traitement de troubles inflammatoires induits par TH2 chez les mammifères non humains, le TSLP des espèces à vacciner est utilisé en tant qu'antigène.
Borden Ladner Gervais Llp
Theravac Pharmaceuticals Ab
LandOfFree
Tslp vaccine for the treatment of th2 mediated inflammatory... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tslp vaccine for the treatment of th2 mediated inflammatory..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tslp vaccine for the treatment of th2 mediated inflammatory... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1779256